The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
insulin detemir · Powder
3 marketed package NDCs · 1 active manufacturer
Most dispensed: 100 [iU]/mL · Injection, Solution · #1 vial, glass/carton / 10 ml in 1 vial, glass
Same drug class
Other molecules FDA puts in Insulin Analog, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- attention deficit mild drops· 1 maker
- attention deficit severe drops· 1 maker
- dna insulin drops· 1 maker
- insulin aspart injection· 1 maker
- insulin aspart-fsan· 1 maker
- insulin aspart-xjhz· 1 maker
- insulin degludec and liraglutide· 1 maker
- insulin glargine and lixisenatide· 1 maker
- insulin glargine-aldy· 1 maker
- insulin glulisine· 1 maker
- pancreas db liquescence· 1 maker
- insulin· 2 makers
Common questions
- Is Insulin detemir in shortage right now?
- No. FDA does not currently list Insulin detemir in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Insulin detemir?
- 4 companies have marketed Insulin detemir in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.